Organization: Health Canada
Year: 2022
Month: September
Request Number: A-2022-000334
Request Summary: Adverse Drug Reactions (ADRs) for C1 Esterase Inhibitor (Human). Report numbers: E2B_05283761, E2B_05309974, E2B_05211532. ADRs for Immunoglobulin (human). Report numbers: E2B_05220640, E2B_05236688, E2B_05220969, E2B_05279639, E2B_05221297, 987550. ADR for Icatibant (icatibant acetate). Report number: E2B_05274039.
Disposition: Disclosed in part
Number of pages: 87